Yüklüyor......
Could plasma sphingolipids be diagnostic or prognostic biomarkers for Alzheimer’s disease?
Understanding the etiopathological processes of Alzheimer’s disease (AD) in the preclinical and early clinical stages will be important in developing new therapeutic targets and biomarkers. There is growing consensus that nonamyloid targets will be necessary to reverse or slow AD progression. Lipido...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2012
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3627378/ https://ncbi.nlm.nih.gov/pubmed/23606909 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/clp.12.59 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|